Assignee
WYETH LLC
US·257 granted patents·112 pending applications·1,808 citations·filing 2001–2025
Top patents by PatentIndex Score
369 records- 0198US10716848B2Process for preparing pneumococcal polysaccharide-protein conjugatesWYETH LLC·Filed 2020·Granted Jul 21, 2020·9 cites·13 claims
- 0298US7951907B2Circovirus sequences associated with piglet weight loss disease (PWD)WYETH LLC·Filed 2009·Granted May 31, 2011·42 cites·7 claims
- 0397US10406220B2Pneumococcal dosing regimenWYETH LLC·Filed 2017·Granted Sep 10, 2019·24 cites·9 claims
- 0497US9669084B2Pneumococcal dosing regimenWYETH LLC·Filed 2014·Granted Jun 6, 2017·33 cites·16 claims
- 0597US9187536B1Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2015·Granted Nov 17, 2015·19 cites·20 claims
- 0697US7888486B2Antagonist antibodies against GDF-8WYETH LLC·Filed 2006·Granted Feb 15, 2011·86 cites·22 claims
- 0796US10774117B2Compositions relating to a mutant clostridium difficile toxin and methods thereofWYETH LLC·Filed 2017·Granted Sep 15, 2020·6 cites·31 claims
- 0896USRE44768ERapamycin hydroxyestersWYETH LLC·Filed 2013·Granted Feb 18, 2014·46 cites·26 claims
- 0996US8557548B2Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2013·Granted Oct 15, 2013·25 cites·21 claims
- 1096US7959927B2Mycoplasma hyopneumoniae bacterin vaccineWYETH LLC·Filed 2009·Granted Jun 14, 2011·27 cites·16 claims
- 1196US7955605B2Multivalent pneumococcal polysaccharide-protein conjugate compositionWYETH LLC·Filed 2006·Granted Jun 7, 2011·47 cites·15 claims
- 1296US7709001B2Multivalent pneumococcal polysaccharide-protein conjugate compositionWYETH LLC·Filed 2006·Granted May 4, 2010·60 cites·16 claims
- 1395US12303592B2Formulations for parenteral delivery of compounds and uses thereofWYETH LLC·Filed 2023·Granted May 20, 2025·1 cites·19 claims
- 1495US11077180B2Non-lipidated variants of Neisseria meningitidis ORF2086 antigensWYETH LLC·Filed 2019·Granted Aug 3, 2021·8 cites·2 claims
- 1595US9981035B2Process for preparing pneumococcal polysaccharide-protein conjugatesWYETH LLC·Filed 2016·Granted May 29, 2018·15 cites·4 claims
- 1695US9745354B2Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2014·Granted Aug 29, 2017·15 cites·28 claims
- 1795USRE46518ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2016·Granted Aug 22, 2017·9 cites·48 claims
- 1895US9399060B2Multivalent pneumococcal polysaccharide-protein conjugate compositionWYETH LLC·Filed 2014·Granted Jul 26, 2016·21 cites·13 claims
- 1995US8900597B2Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2013·Granted Dec 2, 2014·15 cites·41 claims
- 2095US8044178B2Anti-5T4 antibodies and uses thereofWYETH LLC·Filed 2007·Granted Oct 25, 2011·41 cites·31 claims
- 2195US7645752B2Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptorsWYETH LLC·Filed 2007·Granted Jan 12, 2010·59 cites·29 claims
- 2294USRE48862ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Dec 28, 2021·3 cites·20 claims
- 2394US10597428B2Compositions relating to a mutant clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Mar 24, 2020·7 cites·20 claims
- 2494USRE46376ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2015·Granted Apr 25, 2017·9 cites·21 claims
- 2594US7982043B2Protein tyrosine kinase enzyme inhibitorsWYETH LLC·Filed 2008·Granted Jul 19, 2011·13 cites·1 claims
- 2694US7884109B2Purine and imidazopyridine derivatives for immunosuppressionWYETH LLC·Filed 2007·Granted Feb 8, 2011·58 cites·5 claims
- 2794US7714111B2Arginine derivative wash in protein purification using affinity chromatographyWYETH LLC·Filed 2007·Granted May 11, 2010·25 cites·47 claims
- 2893USRE48863ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Dec 28, 2021·3 cites·20 claims
- 2993US10512681B2Non-lipidated variants of Neisseria meningitidis ORF2086 antigensWYETH LLC·Filed 2017·Granted Dec 24, 2019·12 cites·20 claims
- 3093US9981045B2Multivalent pneumococcal polysaccharide-protein conjugate compositionWYETH LLC·Filed 2015·Granted May 29, 2018·13 cites·8 claims
- 3193US8956608B2Method for treating sarcopenia using antagonist antibodies against GDF-8WYETH LLC·Filed 2013·Granted Feb 17, 2015·16 cites·19 claims
- 3293US7879828B2Tigecycline compositions and methods of preparationWYETH LLC·Filed 2006·Granted Feb 1, 2011·16 cites·23 claims
- 3393US7758860B2Protein formulations with reduced viscosity and uses thereofWYETH LLC·Filed 2008·Granted Jul 20, 2010·44 cites·19 claims
- 3492US9480736B2Multivalent pneumococcal polysaccharide-protein conjugate compositionWYETH LLC·Filed 2014·Granted Nov 1, 2016·13 cites·4 claims
- 3592US8383857B2Processes for making hydrazidesWYETH LLC·Filed 2012·Granted Feb 26, 2013·6 cites·19 claims
- 3692US8372625B2Polynucleotides encoding antagonist antibodies against GDF-8WYETH LLC·Filed 2011·Granted Feb 12, 2013·16 cites·23 claims
- 3792US8350013B2Arginine wash in protein purification using affinity chromatographyWYETH LLC·Filed 2007·Granted Jan 8, 2013·19 cites·16 claims
- 3892US8039469B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2009·Granted Oct 18, 2011·15 cites·17 claims
- 3992US7910107B2Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disordersWYETH LLC·Filed 2009·Granted Mar 22, 2011·29 cites·14 claims
- 4091US11535652B2Compositions relating to a mutant clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Dec 27, 2022·2 cites·19 claims
- 4191US10022381B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2015·Granted Jul 17, 2018·5 cites·6 claims
- 4291US8748421B2Triazine compounds as P13 kinase and MTOR inhibitorsWYETH LLC·Filed 2013·Granted Jun 10, 2014·11 cites·9 claims
- 4391US8562999B2Formulations which stabilize and inhibit precipitation of immunogenic compositionsWYETH LLC·Filed 2012·Granted Oct 22, 2013·21 cites·22 claims
- 4491US8496934B2Method for treating cachexia using antagonist antibodies against GDF-8WYETH LLC·Filed 2012·Granted Jul 30, 2013·13 cites·19 claims
- 4591US8022216B2Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofWYETH LLC·Filed 2008·Granted Sep 20, 2011·14 cites·4 claims
- 4691US7901684B2Antibodies against human IL-22 and uses thereforWYETH LLC·Filed 2007·Granted Mar 8, 2011·14 cites·10 claims
- 4791US7750122B2Anti-TrkB monoclonal antibodies and uses thereofWYETH LLC·Filed 2006·Granted Jul 6, 2010·28 cites·27 claims
- 4891US7666439B2Mycoplasma hyopneumoniae bacterin vaccineWYETH LLC·Filed 2006·Granted Feb 23, 2010·7 cites·5 claims
- 4990US7935787B2Formulations which stabilize and inhibit precipitation of immunogenic compositionsWYETH LLC·Filed 2007·Granted May 3, 2011·19 cites·26 claims
- 5090US7754689B2Finger-1 peptide analogs of the TGF-β superfamilyWYETH LLC·Filed 2007·Granted Jul 13, 2010·16 cites·8 claims
Showing the top 50 of 369 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →